Capecitabine for treating head and neck cancer.

Related Articles Capecitabine for treating head and neck cancer. Expert Opin Investig Drugs. 2016 Jul;25(7):851-9 Authors: Iqbal H, Pan Q Abstract INTRODUCTION: With an increasing incidence, over half a million cases of head and neck cancer (HNC) are diagnosed annually worldwide. Various chemotherapeutic agents are utilized to achieve adequate locoregional control. Cisplatin, fluorouracil (FU), and taxanes are often used to treat HNC but these regimens have shown high toxicity and poor patient compliance. Capecitabine is an orally administered prodrug that is preferentially converted to FU in tumor cells in comparison to normal cells. AREA COVERED: In this review, the authors…
Origen: Capecitabine for treating head and neck cancer. – PubMed